Templates Download below:

Manuscripts accepted for publication will be published as open-access articles, immediately free to read, download, and share.

contact: tpb@nabea.pub 

The average submission to the first decision is 2 weeks.

Plagiarism screening policy:

Trends in Pharmaceutical Biotechnology (TPB) does not allow any form of plagiarism. Following our journal policy, submitted manuscripts are screened with plagiarism software to detect instances of overlapping and similar texts by editors and reviewers.

The primary criteria for acceptance and publication are scientific rigor and the potential to advance the field. Authors must prepare their manuscripts according to established specifications. Failure to follow them may result in papers being delayed or rejected. Therefore, contributors are strongly encouraged to read these instructions carefully before preparing a manuscript for submission. The manuscripts should be checked carefully for grammatical errors. All papers are subjected to peer review.

Manuscript Submission

 All papers submitted to the Journal must follow these guidelines. Failure to do so will result in the manuscript being returned to the author and a probable delay in publication. Manuscripts can be submitted using the Internet. Beginning with the title page, all pages should be numbered sequentially in the upper right-hand corner.

ORCID

The journal expects the submitting author (alone) to supply an ORCID iD when submitting an article as part of our commitment to assisting writers at every step of the publication process. It takes about 2 minutes to perform this task. For more information, go here.

Covering Letter

A submission template of a cover letter is available Within the System.

Conflict of Interest

Between the Acknowledgements and References sections, all authors should state all relevant and prospective conflicts of interest as "Conflict of Interest." If any of the manuscript's authors is a current Editor or Editorial Board Member of TPB, please provide that information in your comment. As part of the initial manuscript submission procedure, all authors will be asked to fill out a conflict of interest declaration form. The corresponding author is in charge of collecting completed forms from all manuscript authors.

Ethical Considerations

Authors must mention that the protocol for the research study has been authorized by a properly formed Ethics Committee of the institution where the work was done and that it complies with the rules of the Human Subjects Protection Act.  Declaration of Helsinki. All human subjects research must contain a statement stating that the subject granted informed permission. The privacy of patients should be protected. Photographs must be edited so that human subjects are not identifiable (or an eye bar should be used). Any animal trials must be shown to be ethically appropriate and, when applicable, follow national criteria for animal use in research.

Parts of the Manuscript

The sections of a manuscript should be presented in the following order: I the title page, (ii) the abstract, abbreviations, and the clinical trial register with their clinical registration number at the conclusion of the abstract, (viii) references, (ix) appendices (if any), (x) figure legends, (xi) a list of Supporting Information (if any; with the codec used if they are videos), (xii) tables (each table complete with title and footnotes), (xii) figures Text footnotes are not permitted; instead, such information should be included into the text as parenthetical stuff.

Word count

The number of words allowed for each article category should not be exceeded. The word count for the Original Article includes the title page, abstract, and figure legends. The title page, abstract, references, and figure legends are all included in the word count for the other article categories.

  1. Original article length: up to 5000 words (excluding references), plus a 250-word abstract. There are no restrictions on the number of tables and figures that can be included.
  2. A review paper should be 4000-5000 words long (with up to 80 references), with a 250-word abstract and 4–6 tables or figures in total.
  3. Mini-reviews are summaries of recent insights in specific research areas within the scope of the Journal.
  4. Short communications are suitable for the presentation of research that extends previously published research, including the reporting of additional controls and confirmatory results in other settings, as well as negative results.
  5. A letter to the editor (sometimes abbreviated LTTE or LTE) is a letter sent to a publication about issues of concern from its readers. In academic publishing, letters to the editor of an academic journal are usually open post-publication reviews of a paper, often critical of some aspect of the original paper.

 

Main document: Word

  1. Title page.
  2. Abstract.
  3. Keywords.
  4. Introduction.
  5. Materials and Methods.
  6. Results.
  7. Discussion.
  8. Conclusion.
  9. Acknowledgments.
  10. Conflict of interest.
  11. Reference.

 

References

All references should be numbered sequentially in order of appearance and as thorough as feasible. Citations in the text should be in numerical sequence, using Arabic superscript numerals. Citing and referencing: Vancouver and add DOI for each reference:

Example:

  • Huang AL, Bosco JJ, Peter K. Mast Cell: An Un-expected Villain in Venous Thromboembolism?Circulation Research. 2017;121(8):899-901. doi:https://doi.org/10.1161/CIRCRESAHA.117.311777 
  • Ahad A.; Direct Oral Anticoagulants in The Treatment Of Acute Venous Thromboembolism in Patients With Obesity. Journal of Biomedicine and Biochemistry. 2023;2(3):17-27. doi:10.57238/jbb.2023.6960.1038

 

Submission of Final Checklist

To download the Submission Checklist.

  1. Read the Journal's Guide for Authors and make sure that the manuscript (text, tables, and figures) meets Journal requirements.
  2. The manuscript contains the main sections outlined in the Journal's Guide for Authors.
  3. Spell-check the Manuscript.
  4. All authors must read the Ethics in publishing, Plagiarism prevention, Violation of publication ethics, and Handling misconduct cases before being submitted to the TPB.
  5. The manuscript has been read and approved by all listed authors.
  6. The Corresponding Author and the contributors of the manuscript are advised to be registered at the journal website to keep their names in the manuscript bio-sketches.

Guide How to submit a manuscript